ArticleBiology direct2024

Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway.

Lianglei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.